Patents by Inventor Marianne Allard

Marianne Allard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BACTERIAL VACCINE COMPONENTS AND USES THEREOF
    Publication number: 20210393762
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: August 24, 2021
    Publication date: December 23, 2021
    Inventors: FRANCOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CELINE STER
  • BACTERIAL VACCINE COMPONENTS AND USES THEREOF
    Publication number: 20210322532
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0442, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Inventors: Francois MALOUIN, Marianne ALLARD, Christian LEBEAU JACOB, Brian Geoffrey TALBOT, Daniel SCHOLL, Pierre LACASSE, Moussa S. DIARRA, Celine STER
  • Bacterial vaccine components and uses thereof
    Patent number: 11129884
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: September 28, 2021
    Assignee: SOCPRA—SCIENCES ET GENIE, s.e.c.
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Celine Ster
  • Bacterial vaccine components and uses thereof
    Patent number: 11065322
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0442, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: July 20, 2021
    Assignee: SOCPRA—SCIENCES ET GENIE, s.e.c.
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Celine Ster
  • BACTERIAL VACCINE COMPONENTS AND USES THEREOF
    Publication number: 20200188501
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0442, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: January 22, 2020
    Publication date: June 18, 2020
    Inventors: FRANCOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CELINE STER
  • BACTERIAL VACCINE COMPONENTS AND USES THEREOF
    Publication number: 20200147197
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: January 22, 2020
    Publication date: May 14, 2020
    Inventors: FRANCOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CELINE STER
  • Bacterial vaccine components and uses thereof
    Patent number: 10576139
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: March 3, 2020
    Assignee: SOCPRA—SCIENCES ET GÉNIE, s.e.c.
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • BACTERIAL VACCINE COMPONENTS AND USES THEREOF
    Publication number: 20180289791
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 11, 2018
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • Bacterial vaccine components and uses thereof
    Patent number: 10029004
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: July 24, 2018
    Assignee: SOCPRA—SCIENCES ET GÉNIE, S.E.C.
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • Guanine riboswitch binding compounds and their use as antibiotics
    Patent number: 9993491
    Abstract: The present invention includes novel compounds and pharmaceutically acceptable formulations of said compounds which exhibit antibiotic activity against microorganisms bearing a guanine riboswitch that controls the expression of the guaA gene, including organisms which are resistant to certain antibiotic families, and which are useful as antibacterial agents for treatment or prophylaxis of bacterial infections in animals or in humans, in particular but not limited to infections of the mammary gland, or their use as antiseptics, agents for sterilization or disinfection.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: June 12, 2018
    Assignee: SOCPRA—SCIENCES ET GÉNIE S.E.C.
    Inventors: Jerome Mulhbacher, Daniel Lafontaine, Francois Malouin, Marianne Allard, Eric Marsault
  • BACTERIAL VACCINE COMPONENTS AND USES THEREOF
    Publication number: 20170095548
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: November 7, 2016
    Publication date: April 6, 2017
    Inventors: FRANÇOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CÉLINE STER
  • Bacterial vaccine components and uses thereof
    Patent number: 9566322
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: February 14, 2017
    Assignee: SOCPRA—SCIENCES ET GÉNIE, S.E.C.
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • GUANINE RIBOSWITCH BINDING COMPOUNDS AND THEIR USE AS ANTIBIOTICS
    Publication number: 20150150890
    Abstract: The present invention includes novel compounds and pharmaceutically acceptable formulations of said compounds which exhibit antibiotic activity against microorganisms bearing a guanine riboswitch that controls the expression of the guaA gene, including organisms which are resistant to certain antibiotic families, and which are useful as antibacterial agents for treatment or prophylaxis of bacterial infections in animals or in humans, in particular but not limited to infections of the mammary gland, or their use as antiseptics, agents for sterilization or disinfection.
    Type: Application
    Filed: February 6, 2015
    Publication date: June 4, 2015
    Inventors: JEROME MULHBACHER, DANIEL LAFONTAINE, FRANCOIS MALOUIN, MARIANNE ALLARD, ERIC MARSAULT
  • BACTERIAL VACCINE COMPONENTS AND USES THEREOF
    Publication number: 20150132335
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: October 14, 2014
    Publication date: May 14, 2015
    Inventors: FRANÇOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CÉLINE STER
  • Bacterial vaccine components from and uses thereof
    Patent number: 8889150
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: November 18, 2014
    Assignee: SOCPRA—Sciences et Génie, s.e.c.
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa Sory Diarra, Celine Ster
  • BACTERIAL VACCINE COMPONENTS FROM STAPHYLOCOCCUS AUREUS AND USES THEREOF
    Publication number: 20130064845
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: March 17, 2011
    Publication date: March 14, 2013
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Celine Ster
  • GUANINE RIBOSWITCH BINDING COMPOUNDS AND THEIR USE AS ANTIBIOTICS
    Publication number: 20120122819
    Abstract: The present invention includes novel compounds and pharmaceutically acceptable formulations of said compounds which exhibit antibiotic activity against microorganisms bearing a guanine riboswitch that controls the expression of the guaA gene, including organisms which are resistant to certain antibiotic families, and which are useful as antibacterial agents for treatment or prophylaxis of bacterial infections in animals or in humans, in particular but not limited to infections of the mammary gland, or their use as antiseptics, agents for sterilization or disinfection.
    Type: Application
    Filed: June 14, 2010
    Publication date: May 17, 2012
    Applicant: SOCPRA - SCIENCES ET GENIE S.E.C.
    Inventors: Jérôme Mulhbacher, Daniel Lafontaine, François Malouin, Marianne Allard, Eric Marsault